Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2022 | The importance of UC tumor characterization for personalized medicine

Wesley Yip • 18 Feb 2022
GU Cancers 2022
Bladder Cancer Genitourinary Cancer Urothelial Carcinoma

Wesley Yip, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, outlines the importance of characterizing a tumors molecular profile to inform personalization of medicine. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.

More from Wesley Yip

1:55
Upper tract UC transcriptome profiling and immune microenvironment characterization
Wesley Yip • 18 Feb 2022
1:34
The effect of remote learning on clinical practice for urothelial carcinoma (UC)
Wesley Yip • 18 Feb 2022
2:13
Neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
Wesley Yip • 18 Feb 2022

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals